Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03348410
Other study ID # GESAM2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 14, 2017
Est. completion date December 14, 2019

Study information

Verified date October 2020
Source Uppsala University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

GESAM is a randomized controlled intervention study that addressed women and men on long-term sick leave in Uppsala County. Participants which are on sick leave due to mental illness and/or pain and were expected to reach the time limit within the in health insurance will be offered to participate in an intervention. Those how give informed consent will be randomly assigned one of the following groups: 1) informing and motivating intervention with insurance officer 2) control group. The main purpose of the study is to facilitate the return to work (preventing a return to the public health insurance) during the project period.


Recruitment information / eligibility

Status Completed
Enrollment 193
Est. completion date December 14, 2019
Est. primary completion date November 14, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - On sick leave - Risk of losing sick leave compensation Exclusion Criteria: - Major mental illness (schizophrenia, bipolar disorder type I, severe social dysfunction/personality disorder) - Cancer disease

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational interviewing
Motivational interviewing with insurance officer

Locations

Country Name City State
Sweden Uppsala university Uppsala

Sponsors (1)

Lead Sponsor Collaborator
Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Return to work (RTW) Return to work measured as time to participation in the labor force One year